Pluvia
Bergen, NO · 2 known investors
Pluvia Biotech is a University of Bergen spin-out developing small molecule pharmacological chaperones that stabilize and correct misfolded proteins to rescue enzymatic activity in rare genetic loss-of-function disorders. Its lead program, PBAS499, targets phenylketonuria (PKU), an inborn metabolic disorder, with plans to apply its drug discovery platform to other protein-misfolding diseases.
BiotechDeep TechHealthtech
Founders & leadership
WV
Willem van WeperenCEO
TV
Torgeir VaageCFO
AM
Aurora MartinezCTO
Investors · 2
Frequently asked questions
- What does Pluvia do?
- Pluvia Biotech is a University of Bergen spin-out developing small molecule pharmacological chaperones that stabilize and correct misfolded proteins to rescue enzymatic activity in rare genetic loss-of-function disorders. Its lead program, PBAS499, targets phenylketonuria (PKU), an inborn metabolic disorder, with plans to apply its drug discovery platform to other protein-misfolding diseases.
- Who are Pluvia's investors?
- Pluvia's investors include Investinor, Sarsia Management AS.
- Where is Pluvia headquartered?
- Pluvia is headquartered in Bergen, NO.